Diphtheria and Tetanus Antitoxoids
Use
Used to evaluate diphtheria immunization response. Antibody levels of ≥ 0.10 IU/mL are considered protective. Tetanus is caused by Clostridium tetani. Immunization with Tetanus Antitoxoid is effective with boosters in immunocompetent individuals. Antibody levels of ≥ 0.10 IU/mL are considered protective. However, tetanus can still occur in some individuals with such antibody levels. These results should not be used to determine the necessity to administer antitoxin when clinically indicated.
Special Instructions
Not provided.
Limitations
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
New York Approved
Methodology
Immunoassay
Biomarkers
Diphtheria Antitoxoid
AnalyteTetanus Antitoxoid
Analyte
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL (0.3 mL minimum) in each of two separate tubes
Minimum Volume
0.3 mL
Container
serum separator tube or plain red tube (centrifuge and aliquot)
Collection Instructions
2 mL (0.3 mL minimum) serum collected in each of two separate tubes
Other tests from different labs that may be relevant